Triple-transgenic model of Alzheimer's Disease with plaques and tangles: Intracellular Aβ and synaptic dysfunction

Neuron

Volumn 39, Issue 3, 2003, Pages 409-421

  Oddo, Salvatore ^a   Caccamo, Antonella ^a   Shepherd, Jason D ^a   Murphy, M Paul ^c   Golde, Todd E ^c   Kayed, Rakez ^b   Metherate, Raju ^a   Mattson, Mark P ^d   Akbari, Yama ^a   LaFerla, Frank M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MAYO CLINIC   (United States)

^d NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; EXPERIMENTAL MOUSE; HOMOZYGOSITY; KNOCKIN MOUSE; LONG TERM POTENTIATION; MOLECULAR INTERACTION; MOUSE; NERVE CELL PLASTICITY; NEUROFIBRILLARY TANGLE; NONHUMAN; PRIORITY JOURNAL; SENILE PLAQUE; SYNAPTIC TRANSMISSION; TRANSGENE;

EID: 0042697305     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-6273(03)00434-3     Document Type: Article

References (48)

1. Bliss T.V., Collingridge G.L. A synaptic model of memory. long-term potentiation in the hippocampus Nature. 361:1993;31-39.
2. Caroni P. Overexpression of growth-associated proteins in the neurons of adult transgenic mice. J. Neurosci. Methods. 71:1997;3-9.
3. Chapman P.F., White G.L., Jones M.W., Cooper-Blacketer D., Marshall V.J., Irizarry M., Younkin L., Good M.A., Bliss T.V., Hyman B.T.et al. Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat. Neurosci. 2:1999;271-276.
4. Chui D.H., Tanahashi H., Ozawa K., Ikeda S., Checler F., Ueda O., Suzuki H., Araki W., Inoue H., Shirotani K.et al. Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation. Nat. Med. 5:1999;560-564.
5. DeKosky S.T., Scheff S.W. Synapse loss in frontal cortex biopsies in Alzheimer's disease. correlation with cognitive severity Ann. Neurol. 27:1990;457-464.
6. Dickson D.W., Crystal H.A., Bevona C., Honer W., Vincent I., Davies P. Correlations of synaptic and pathological markers with cognition of the elderly. Neurobiol. Aging. 16:1995;285-304.
7. Fitzjohn S.M., Morton R.A., Kuenzi F., Rosahl T.W., Shearman M., Lewis H., Smith D., Reynolds D.S., Davies C.H., Collingridge G.L.et al. Age-related impairment of synaptic transmission but normal long-term potentiation in transgenic mice that overexpress the human APP695SWE mutant form of amyloid precursor protein. J. Neurosci. 21:2001;4691-4698.
8. Flood D.G., Coleman P.D. Hippocampal plasticity in normal aging and decreased plasticity in Alzheimer's disease. Prog. Brain Res. 83:1990;435-443.
9. Gotz J., Chen F., Barmettler R., Nitsch R.M. Tau filament formation in transgenic mice expressing P301L tau. J. Biol. Chem. 276:2001;529-534. a.
10. Gotz J., Chen F., van Dorpe J., Nitsch R.M. Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils. Science. 293:2001;1491-1495. b.
11. Gouras G.K., Tsai J., Naslund J., Vincent B., Edgar M., Checler F., Greenfield J.P., Haroutunian V., Buxbaum J.D., Xu H.et al. Intraneuronal Abeta42 accumulation in human brain. Am. J. Pathol. 156:2000;15-20.
12. Grundke-Iqbal I., Iqbal K., George L., Tung Y.C., Kim K.S., Wisniewski H.M. Amyloid protein and neurofibrillary tangles coexist in the same neuron in Alzheimer disease. Proc. Natl. Acad. Sci. USA. 86:1989;2853-2857.
13. Guo Q., Fu W., Sopher B.L., Miller M.W., Ware C.B., Martin G.M., Mattson M.P. Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice. Nat. Med. 5:1999;101-106.
14. Gyure K.A., Durham R., Stewart W.F., Smialek J.E., Troncoso J.C. Intraneuronal abeta-amyloid precedes development of amyloid plaques in Down syndrome. Arch. Pathol. Lab. Med. 125:2001;489-492.
15. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease. progress and problems on the road to therapeutics Science. 297:2002;353-356.
16. Higuchi M., Ishihara T., Zhang B., Hong M., Andreadis A., Trojanowski J., Lee V.M. Transgenic mouse model of tauopathies with glial pathology and nervous system degeneration. Neuron. 35:2002;433-446.
17. Hsia A.Y., Masliah E., McConlogue L., Yu G.Q., Tatsuno G., Hu K., Kholodenko D., Malenka R.C., Nicoll R.A., Mucke L. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc. Natl. Acad. Sci. USA. 96:1999;3228-3233.
18. Kamenetz F., Tomita T., Hsieh H., Seabrook G., Borchelt D., Iwatsubo T., Sisodia S., Malinow R. APP processing and synaptic function. Neuron. 37:2003;925-937.
19. Kayed R., Head E., Thompson J.L., McIntire T.M., Milton S.C., Cotman C.W., Glabe C.G. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science. 300:2003;486-489.
20. Kuo Y.M., Beach T.G., Sue L.I., Scott S., Layne K.J., Kokjohn T.A., Kalback W.M., Luehrs D.C., Vishnivetskaya T.A., Abramowski D.et al. The evolution of A beta peptide burden in the APP23 transgenic mice. implications for A beta deposition in Alzheimer disease Mol. Med. 7:2001;609-618.
21. LaFerla F.M. Calcium dyshomeostasis and intracellular signaling in Alzheimer's disease. Nat. Rev. Neurosci. 3:2002;862-872.
22. LaFerla F.M., Tinkle B.T., Bieberich C.J., Haudenschild C.C., Jay G. The Alzheimer's A beta peptide induces neurodegeneration and apoptotic cell death in transgenic mice. Nat. Genet. 9:1995;21-30.
23. LaFerla F.M., Troncoso J.C., Strickland D.K., Kawas C.H., Jay G. Neuronal cell death in Alzheimer's disease correlates with apoE uptake and intracellular Abeta stabilization. J. Clin. Invest. 100:1997;310-320.
24. Leissring M.A., Akbari Y., Fanger C.M., Cahalan M.D., Mattson M.P., LaFerla F.M. Capacitative calcium entry deficits and elevated luminal calcium content in mutant presenilin-1 knockin mice. J. Cell Biol. 149:2000;793-798.
25. Lewis J., McGowan E., Rockwood J., Melrose H., Nacharaju P., Van Slegtenhorst M., Gwinn-Hardy K., Paul Murphy M., Baker M., Yu X.et al. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat. Genet. 25:2000;402-405.
26. Lewis J., Dickson D.W., Lin W.L., Chisholm L., Corral A., Jones G., Yen S.H., Sahara N., Skipper L., Yager D.et al. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science. 293:2001;1487-1491.
27. Li Q.X., Maynard C., Cappai R., McLean C.A., Cherny R.A., Lynch T., Culvenor J.G., Trevaskis J., Tanner J.E., Bailey K.A.et al. Intracellular accumulation of detergent-soluble amyloidogenic A beta fragment of Alzheimer's disease precursor protein in the hippocampus of aged transgenic mice. J. Neurochem. 72:1999;2479-2487.
28. Masliah E., Mallory M., Alford M., DeTeresa R., Hansen L.A., McKeel D.W. Jr., Morris J.C. Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease. Neurology. 56:2001;127-129.
29. Mendell J.R., Sahenk Z., Gales T., Paul L. Amyloid filaments in inclusion body myositis. Novel findings provide insight into nature of filaments. Arch. Neurol. 48:1991;1229-1234.
30. Mesulam M.M. Neuroplasticity failure in Alzheimer's disease. bridging the gap between plaques and tangles Neuron. 24:1999;521-529.
31. Mesulam M.M. A plasticity-based theory of the pathogenesis of Alzheimer's disease. Ann. N Y Acad. Sci. 924:2000;42-52.
32. Moechars D., Dewachter I., Lorent K., Reverse D., Baekelandt V., Naidu A., Tesseur I., Spittaels K., Haute C.V., Checler F.et al. Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. J. Biol. Chem. 274:1999;6483-6492.
33. Parent A., Linden D.J., Sisodia S.S., Borchelt D.R. Synaptic transmission and hippocampal long-term potentiation in transgenic mice expressing FAD-linked presenilin 1. Neurobiol. Dis. 6:1999;56-62.
34. Scheff S.W., Scott S.A., DeKosky S.T. Quantitation of synaptic density in the septal nuclei of young and aged Fischer 344 rats. Neurobiol. Aging. 12:1991;3-12.
35. Schwab C., McGeer P.L. Abeta42-carboxy-terminal-like immunoreactivity is associated with intracellular neurofibrillary tangles and pick bodies. Exp. Neurol. 161:2000;527-534.
36. Selkoe D.J. Alzheimer's disease. genes, proteins, and therapy Physiol. Rev. 81:2001;741-766.
37. Selkoe D.J. Alzheimer's disease is a synaptic failure. Science. 298:2002;789-791.
38. Sugarman M.C., Yamasaki T.R., Oddo S., Echegoyen J.C., Murphy M.P., Golde T.E., Jannatipour M., Leissring M.A., LaFerla F.M. Inclusion body myositis-like phenotype induced by transgenic overexpression of beta APP in skeletal muscle. Proc. Natl. Acad. Sci. USA. 99:2002;6334-6339.
39. Suzuki N., Cheung T.T., Cai X.D., Odaka A., Otvos L. Jr., Eckman C., Golde T.E., Younkin S.G. An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. Science. 264:1994;1336-1340.
40. Sze C.I., Troncoso J.C., Kawas C., Mouton P., Price D.L., Martin L.J. Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease. J. Neuropathol. Exp. Neurol. 56:1997;933-944.
41. Takahashi R.H., Milner T.A., Li F., Nam E.E., Edgar M.A., Yamaguchi H., Beal M.F., Xu H., Greengard P., Gouras G.K. Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology. Am. J. Pathol. 161:2002;1869-1879.
42. Terry R.D., Masliah E., Salmon D.P., Butters N., DeTeresa R., Hill R., Hansen L.A., Katzman R. Physical basis of cognitive alterations in Alzheimer's disease. synapse loss is the major correlate of cognitive impairment Ann. Neurol. 30:1991;572-580.
43. Thomson A.M. Facilitation, augmentation and potentiation at central synapses. Trends Neurosci. 23:2000;305-312.
44. Walsh D.M., Klyubin I., Fadeeva J.V., Cullen W.K., Anwyl R., Wolfe M.S., Rowan M.J., Selkoe D.J. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature. 416:2002;535-539.
45. Wirths O., Multhaup G., Czech C., Blanchard V., Moussaoui S., Tremp G., Pradier L., Beyreuther K., Bayer T.A. Intraneuronal Abeta accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic mice. Neurosci. Lett. 306:2001;116-120.
46. Wong P.C., Cai H., Borchelt D.R., Price D.L. Genetically engineered mouse models of neurodegenerative diseases. Nat. Neurosci. 5:2002;633-639.
47. Zhang Y., McLaughlin R., Goodyer C., LeBlanc A. Selective cytotoxicity of intracellular amyloid beta peptide1-42 through p53 and Bax in cultured primary human neurons. J. Cell Biol. 156:2002;519-529.
48. Zucker R.S., Regehr W.G. Short-term synaptic plasticity. Annu. Rev. Physiol. 64:2002;355-405.